NeuroMab monoclonal antibodies are validated for biochemical and immunohistochemical applications in mammalian brain samples, including immunoblotting, immunohistochemistry and array tomography. For perspectives on application-specific antibody validation see Taussig et al., New Biotech 45:1, 2018. PubMed.
For information on NeuroMab monoclonal antibody validation see Gong et al., New Biotech 33:551, 2016. PubMed. See detailed sample preparation and labeling protocols used for NeuroMab monoclonal antibody validation.
See publications list for peer-reviewed papers showing data obtained with NeuroMabs, now over >3000 publications!